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Abstract
Background: Feeding normal rats with high dietary levels of saturated fat leads to pathological
conditions, which are quite similar to syndrome X in humans. These conditions such as
hypertriglyceridemia, hypercholesterolemia, obesity, and hyperglycemia might induce hypertension
through various mechanisms. Metabolic syndrome and the resulting NIDDM represent a major
clinical challenge because implementation of treatment strategies is difficult. Vascular abnormalities
probably contribute to the etiology of many diabetic complications including nephropathy,
neuropathy, retinopathy, and cardiomyopathy. It has been shown that in Streptozotocin induced
diabetic animals there is an increase in maximal responses to 5-Hydroxytryptamine and
Angiotensin II. The purpose of this study was to evaluate High fat diet fed rats for the development
of hypertriglyceridemia, hypercholesterolemia, hyperinsulinemia and hyperglycemia and to assess
their vascular responses to 5-Hydroxytryptamine and Angiotensin II.
Methods: Male Sprague Dawley rats were used for this study and were divided into two equal
groups. One of the groups was fed with normal pellet diet and they served as the control group,
whereas the other group was on a high fat diet for 4 weeks. Body weight, plasma triglycerides,
plasma cholesterol, and plasma glucose were measured every week. Intraperitoneal glucose
tolerance test was performed after 4 weeks of feeding. At the end of fourth week of high fat diet
feeding, thoracic aortae were removed, and cut into helical strips for vascular reactivity studies.
Dose-response curves of 5-Hydroxytryptamine and Angiotensin II were obtained.
Results: There was no significant difference in pD2, with 5-Hydroxytryptamine and Angiotensin II
in both groups but Emax was increased.
Conclusions: These results suggest that hypertension in high fat diet rats is associated with
increased in vitro vascular reactivity to 5-HT and Ang II.
Background
Syndrome X comprises a plethora of conditions such as
obesity, dyslipidemia, impaired glucose tolerance, insulin
resistance and hypertension [1]. It places stress on multi-
ple organ systems and plays a significant role in the devel-
opment of other related cardiovascular disorders. Western
style diet, which contains high levels of fat, is also consid-
ered to be one of the main factors in the development of
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obesity and insulin resistance. The most common reason
for the development of hyperinsulinemia (decreased
hepatic insulin clearance and/or increased insulin secre-
tion) from insulin resistance is obesity. Excess fat deposits
in the white adipose tissue affects insulin mediated glu-
cose metabolism in non adipose tissues, causes disor-
dered insulin response and increases lipid deposition [2].
However, pathophysiologies of vascular complications in
syndrome X have not been fully understood. 5-hydrox-
ytryptamine (5-HT) is shown to be related to pathogene-
sis of vasculopathy in diabetes. Various studies in humans
and rabbits have reported increased plasma 5-HT levels
and enhanced contraction to 5-HT in diabetes mellitus [3-
5]. Another vasopressor peptide, Angiotensin II (Ang II) is
involved in cardiovascular complications of diabetes mel-
litus. Many have reported that the vascular Renin angi-
otensin system is one of the key systems in the etiology of
vascular alterations in early stages of diabetes. It is already
established that 5-HT and Ang II responses are altered in
the aortic rings of streptozotocin (STZ) induced diabetic
rats [6,7] and high fructose diet fed rats [8]. However, very
little information is available in the literature regarding
the vascular contractile responses to vasopressor agents
such as 5-HT and Ang II in HFD fed rats.
The aim of this study was to elucidate the contractile
responses to 5-HT and Ang II in HFD fed rat thoracic aorta
which will provide an avenue for further exploratory stud-
ies. We have selected HFD fed rat model for our study
because it is a useful model of the putative effects of excess
fat intake in humans and it represents the major sub type
of diabetes mellitus, non insulin dependent diabetes mel-
litus (NIDDM).
Results
Biochemical measurements
HFD fed rats showed significant increase in body weight
as compared to NPD fed rats (Table 2). In addition, the
rats fed HFD showed significant elevation in the basal
plasma glucose, triglyceride, total cholesterol and insulin
levels at the end of four weeks of dietary manipulation as
compared to NPD fed control groups (Table 2). The HFD
fed rats exhibited significant elevation in basal fasting glu-
cose and showed significant impairment in glucose toler-
ance to exogenously administered glucose (Fig 1).
Estimation of AUC values indicated 28.4 % increase in
plasma glucose of HFD fed when compared to NPD fed
rats.
Vascular Responses
Cumulative concentration response curves of 5-HT and
Ang II for both HFD fed rat thoracic aortae showed an
increase in Emax (Fig 2 and 3) with out any change in pD2
values when compared to NPD fed rats (Table 2). There
was no significant change in both Emax and pD2 values
with KCl in both groups (data not shown). The order of
potency of agonists in both groups was Ang II>5-HT>KCl.
Discussion
Obesity is a major risk factor for several metabolic dis-
eases, frequently clustering to form the metabolic syn-
drome or syndrome X [9]. Obese people have increased
incidence of NIDDM with high percentage of mortality
and morbidity [10]. Western style diet, which is abundant
with calorically dense and saturated fatty foods, is consid-
ered to be the main factor in the development of obesity
and insulin resistance. Our studies have shown that HFD
causes increase in bodyweight when compared to NPD
after four weeks of dietary manipulation in rats.
Hyperglycemia is observed in insulin resistance where
glucose utilization is reduced. We saw significant eleva-
tions in blood glucose levels. Intraperitoneal glucose tol-
erance tests confirm severe glucose intolerance.
Oversupply of dietary lipids causes insulin resistance in
rats [11]. Randle glucose fatty acid cycle suggested that the
body prefers excess lipid stores to glucose for metabolic
oxidation in insulin resistance [12]. Our HFD model also
exhibited high plasma triglyceride levels. Hence studies
on our experimental model in compliance with Randle et
al findings suggested that HFD feeding causes insulin
resistance [13].
Elevated cholesterol is also observed in insulin resistant
individuals. For this reason we measured plasma choles-
terol levels which were found to be more than normal val-
ues. Previous studies have reported a down regulation of
LDL receptors and associated decrease in LDL clearance,
increased total cholesterol levels [15].
Insulin resistance with compensatory hyperinsulinemia is
a prominent feature of metabolic syndrome. The most
common reason for the development of hyperinsuline-
mia in insulin resistance is obesity. It stands as one of the
Table 1: Composition of HFD
(g)
Powdered pellet diet 364
Lard 310
Casein 250
Cholesterol 10
DL-Methionine 3
Yee-sac powder 1
Vitamin and mineral mix powder 60
Sodium chloride 2Lipids in Health and Disease 2004, 3:19 http://www.lipidworld.com/content/3/1/19
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major cardiovascular risk factors in patients with obesity.
The present study on HFD rats demonstrated higher
plasma insulin levels than control values. This marked
hyperinsulinemia could be due to a combination of
increased β-cell mass and decreased insulin clearance, as
well as failure of insulin to suppress hepatic gluconeogen-
esis [14].
According to National Cholesterol Education Program's
Adult Treatment Panel III (Third report) easily measured
clinical findings for syndrome X includes increased
abdominal circumference, elevated triglycerides, low
high-density lipoprotein-cholesterol, and elevated fasting
blood glucose and/or elevated blood pressure. Three of
these five are required for diagnosis. Our study demon-
strated three of the clinical parameters indicating condi-
tions of syndrome X in HFD fed rats [16]. Insulin
resistance along with other conditions of syndrome X
might induce hypertension by a host of mechanisms
involving insulin itself, increased sodium reabsorption
and/or enhanced intra cellular concentration of free cal-
cium in vascular smooth muscle [17]. Although the etiol-
ogy of vascular disorders in metabolic syndrome has not
completely been revealed, it is suggested that alterations
in the reactivity of blood vessels to neurotransmitters and
circulating hormones are responsible for the functional
abnormalities of blood vessels.
In order to elaborate the pathways that connect syndrome
X to hypertension we have studied the contractile
responses to 5-HT and Ang II in both HFD and NPD fed
rat thoracic aortae. Previously we have demonstrated
increased contractile responses with synthetic alpha
adrenoceptor agonist, phenylephrine, in HFD fed rat tho-
racic aorta [18]. This enabled us to explore the role of
these endogenous mediators in the same animal model.
The present vascular studies demonstrated that the magni-
tude of responses to 5-HT and Ang II was significantly
enhanced in HFD fed animals without change in pD2
value. Endothelial denudation obviates any related mech-
anisms such as impairment of NO release, increased
destruction of EDRF and substrate availability for the pro-
duction of EDRF. Hence, the probable reasons for these
enhanced 5-HT and Ang II responses may be due to recep-
tor mediated or non-receptor mediated pathways.
The role of non-receptor mediated contraction can be
ruled out for there was no change in contractile response
to KCl. Vascular studies have also shown functional evi-
dence that hypertension developed in HFD fed rats may
be associated with enhanced vasoreactivity to various
vasoconstrictor agents. Further the enhanced responses to
5-HT in HFD fed rats could be due to increased PKC as
previously reported with STZ and alloxan (ALL) induced
diabetic animals [19]. Increased contractions to 5-HT can
also be related to 5-HT2A upregulation as observed in
spontaneously hypertensive rats or due to serotonin act-
ing through alpha adrenoceptors [20].
Increased Ang II responses in HFD fed rats are may be due
to upregulation of Ang II receptors as observed in hyper-
insulinemia or via amplified secondary messenger sys-
tems [21]. A proposed scheme of events is given in Fig 4.
In summary, the present study has shown that HFD feed-
ing in rats produces conditions similar to syndrome X.
Increased vasocontractile responses observed in the
model are not only mediated via alpha adrenoceptors but
also due to 5-HT and Ang II (see Figure 4).
More robust studies on the secondary messenger systems
of 5-HT and Ang II will provide valuable insights into the
Table 2: Various parameters of NPD and HFD fed rats
Parameter NPD fed HFD fed
Body weight (gm) 259.2 ± 5.3 315.0 ± 6.5***
plasma glucose (mg/dl) 87.5 ± 2.5 111.0 ± 0.9***
Plasma triglycerides (mg/dl) 41.3 ± 1.7 89.7 ± 7.2***
Plasma cholesterol (mg/dl) 48.9 ± 3.7 87.5 ± 2.6***
Plasma Insulin (ng/ml) 1.90 ± 0.15 3.05 ± 0.21*
pD2 of 5-HT 5.74 ± 0.09 6.00 ± 0.06
Emax of 5-HT 30.0 ± 1.8 49.0 ± 2.0**
pD2 of Ang II 7.69 ± 0.08 7.31 ± 0.18
Emax of Ang II 25.0 ± 3.4 34.0 ± 3.0*
Each point is represented as mean ± SEM *p < 0.05, **p < 0.01 and ***p < 0.001 Vs NPD fed groupLipids in Health and Disease 2004, 3:19 http://www.lipidworld.com/content/3/1/19
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mechanisms underlying increased vascular contractility in
insulin resistance.
Materials and Methods
Tissue Preparation
Male Sprague-Dawley rats (central animal facility,
National Institute of Pharmaceutical Education and
Research (NIPER), India), 160–200 g, were kept in con-
trolled environmental conditions with room temperature
22 ± 2°C, humidity 55 ± 5% and 12-h light/dark cycles.
All the animals had free access to food and water. The rats
were divided into two dietary groups and fed with stand-
ard rat normal pellet diet (NPD) (3.8 kcal/g, carbohydrate
67%, protein 21%, fat 12% kcal) and HFD (5.3 kcal/g,
carbohydrate 17%, protein 25%, fat 58% kcal). Composi-
tion of HFD is described in Table 1.
Biochemical measurements
Blood samples from the retro orbital plexus of anaesthe-
tized rats (Pentobarbitone 45 mg/kg, i.p.,) were collected
into the heparinized tubes and immediately centrifuged at
5000 rpm for the separation of plasma. Plasma was stored
at -20°C until assayed. The plasma was used for the esti-
mation of glucose (Qualigens, Mumbai, India), triglycer-
ides, and cholesterol (Chema diagnostica, Jesi, Italy) by
commercial kits. Plasma insulin was determined by radi-
oimmuno assay using rat insulin as standard (Linco
research, St. Charles, MO, USA)
Intra peritoneal glucose tolerance test (IPGTT)
Glucose tolerance tests were carried out after four weeks of
feeding of both NPD and HFD. After an overnight fast,
blood samples were collected from the retro orbital
plexus. Glucose levels were measured at time zero (0 min)
and glucose was injected into the rats (2 g/Kg/4 ml, i.p.,).
Additional blood samples were taken at 15, 30, 60 and
120 min. following the glucose load. Plasma glucose lev-
els were measured by the glucose oxidase reaction (GOD/
POD) using commercial kit (Qualigens, Mumbai, India).
Effect of HFD on intra peritoneal glucose tolerance test  (IPGTT) in rats, as compared to NPD fed group Figure 1
Effect of HFD on intra peritoneal glucose tolerance test 
(IPGTT) in rats, as compared to NPD fed group. All values 
are expressed as mean ± SEM (n = 8) *p < 0.05, **p < 0.01, 
***p < 0.001 Vs NPD fed group
Cumulative concentration response curve to 5-HT in heli- cally cut aortic strip preparations obtained from NPD fed  and HFD fed rats Figure 2
Cumulative concentration response curve to 5-HT in heli-
cally cut aortic strip preparations obtained from NPD fed 
and HFD fed rats. Each point is represented as mean ± SEM 
(n = 5) *p < 0.05, **p < 0.01 Vs NPD fed group
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Area under the curve (AUC) was calculated for both NPD
and HFD fed rats.
Vascular Studies
After 4 weeks of feeding, rats were sacrificed by cervical
dislocation. The section of the aorta from between the
aortic arch and the diaphragm was removed from the
euthanized rats and placed in oxygenated, modified
Krebs-Henseleit solution (KHS; in mM: 118 NaCl, 4.7
KCl, 25 NaHCO3, 2.6 CaCl2 2H2O 1.2 NaH2PO4, 1.2
MgCl2 6H2O, 5.5 glucose). With the help of a steel rod,
aortic endothelium was deliberately denuded. The aorta
was cut into helical strips 3 mm wide, 20 mm long and
then placed in a well-oxygenated (95% O2-5% CO2) bath
of 10-ml KHS with one end connected to a tissue holder
and the other to an isotonic transducer (Bio Devices,
Ambala, India). The tissue was equilibrated for 60 min
under a resting tension of 1.0 g. At the beginning of each
experiment, aortic strips were primed with depolarizing
concentration (90 mM) potassium chloride (KCl). After
the equilibration period, contractile responses to various
concentrations of 5-HT (10 nM-30 µM) and Ang II (1 nM-
300 nM) were recorded.
Data analysis
Contraction responses are expressed as percentage. For
each contractile agent, both the maximal contraction
(Emax) and the concentration necessary to produce 50% of
its maximal response (EC50) were determined. The EC50
values were converted to the negative logarithms and
expressed as pD2. Results were shown as mean ± SEM; n
refers to the number of animals from which vessels were
taken. Agonist potencies and maximal effects were com-
pared by student's t  test by using statistical software
Cumulative concentration response curve to Ang II in heli- cally cut aortic strip preparations obtained from NPD fed  and HFD fed rats Figure 3
Cumulative concentration response curve to Ang II in heli-
cally cut aortic strip preparations obtained from NPD fed 
and HFD fed rats. Each point is represented as mean ± SEM 
(n = 5) *p < 0.05, **p < 0.01 Vs NPD fed group
-9 -8 -7 -6
0
25
50
75
100
125
150 NPD fed
HFD fed
*
Log [M] Ang - II
%
 
R
e
s
p
o
n
s
e
Proposed events underlying syndrome X in HFD rats Figure 4
Proposed events underlying syndrome X in HFD rats. HFD 
leads to condition, in rats, similar to syndrome X. This 
includes obesity, insulin resistance, hyperglycemia and dyslipi-
demia which all are interrelated. These events are the initial 
steps in the cascade towards hypertension. This could be 
mediated via increased contractile responses to various 
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(GraphPad Prism 3.01). Values were considered signifi-
cantly different at p < 0.05.
Drugs and solutions
The following drugs were used in this study: 5-HT (RBI,
USA), Ang II (Bachem, Switzerland), All drugs were dis-
solved in KHS. Drugs were added to the organ chambers
in volumes not greater than 0.2 ml.
List of abbreviations
HFD – High fat diet
NPD – Normal pellet diet
NIDDM – Non insulin dependent diabetes mellitus
STZ – Streptozotocin
5-HT – 5-Hydroxytryptamine
Ang II – Angiotensin II
KHS – Krebs-Henseleit solution
GOD/POD – Glucose oxidase/peroxidase
AUC – area under the curve
Emax – Maximal response
EC50 – Concentration required producing 50% of maxi-
mal response
pD2 – -log EC50
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